-
1
-
-
70350464539
-
Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia
-
Alavian, S.M., Miri, S.M., Keshvari, M., Elizee, P.K., Behnava, B., Tabatabaei, S.V., et al. 2009. Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia. Transfusion, 49(10): 2195–2199. doi:10.1111/j.1537-2995.2009.02252.x. PMID:19538541.
-
(2009)
Transfusion
, vol.49
, Issue.10
, pp. 2195-2199
-
-
Alavian, S.M.1
Miri, S.M.2
Keshvari, M.3
Elizee, P.K.4
Behnava, B.5
Tabatabaei, S.V.6
-
2
-
-
77955016528
-
Hepatitis C infection in hemodialysis patients in Iran: A systematic review
-
Alavian, S.M., Kabir, A., Ahmadi, A.B., Lankarani, K.B., Shahbabaie, M.A., and Ahmadzad-Asl, M. 2010. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial. Int. 14(3): 253–262. doi:10.1111/j.1542-4758.2010.00437.x. PMID:20491973.
-
(2010)
Hemodial. Int
, vol.14
, Issue.3
, pp. 253-262
-
-
Alavian, S.M.1
Kabir, A.2
Ahmadi, A.B.3
Lankarani, K.B.4
Shahbabaie, M.A.5
Ahmadzad-Asl, M.6
-
3
-
-
81555219121
-
Virus-triggered autophagy in viral hepatitis - Possible novel strategies for drug development
-
Alavian, S.M., Ande, S.R., Coombs, K.M., Yeganeh, B., Davoodpour, P., Hashemi, M., et al. 2011. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. J. Viral Hepat. 18(12): 821–830. doi:10.1111/j.1365-2893.2011.01530.x. PMID:22093031.
-
(2011)
J. Viral Hepat
, vol.18
, Issue.12
, pp. 821-830
-
-
Alavian, S.M.1
E, S.R.2
Coombs, K.M.3
Yeganeh, B.4
Davoodpour, P.5
Hashemi, M.6
-
4
-
-
0027068086
-
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team
-
Alter, M.J., Margolis, H.S., Krawczynski, K., Judson, F.N., Mares, A., Alexander, W.J., et al. 1992. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327(27): 1899–1905. PMID:1280771.
-
(1992)
N. Engl. J. Med
, vol.327
, Issue.27
, pp. 1899-1905
-
-
Alter, M.J.1
Margolis, H.S.2
Krawczynski, K.3
Judson, F.N.4
Mares, A.5
Alexander, W.J.6
-
5
-
-
79953858689
-
Lysosomotropic agents as HCV entry inhibitors
-
Ashfaq, U.A., Javed, T., Rehman, S., Nawaz, Z., and Riazuddin, S. 2011. Lysosomotropic agents as HCV entry inhibitors. Virol. J. 8: 163. doi:10.1186/1743-422X-8-163. PMID:21481279.
-
(2011)
Virol. J
, vol.8
-
-
Ashfaq, U.A.1
Javed, T.2
Rehman, S.3
Nawaz, Z.4
Riazuddin, S.5
-
6
-
-
0142240117
-
Twenty-four vs. Forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
-
August-Jorg, B.S., Borovicka, J., Dufour, J.F., Gonvers, J.J., Henz, S., Hermann, R., et al. 2003. Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. Swiss Med. Wkly. 133(33–34): 455–460. PMID:14625812.
-
(2003)
Swiss Med. Wkly
, vol.133
, Issue.33-34
, pp. 455-460
-
-
August-Jorg, B.S.1
Borovicka, J.2
Dufour, J.F.3
Gonvers, J.J.4
Henz, S.5
Hermann, R.6
-
7
-
-
33947360829
-
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
-
Bruno, S., Stroffolini, T., Colombo, M., Bollani, S., Benvegnu, L., Mazzella, G., et al. 2007. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology, 45(3): 579–587. doi:10.1002/hep.21492. PMID:17326216.
-
(2007)
Hepatology
, vol.45
, Issue.3
, pp. 579-587
-
-
Bruno, S.1
Stroffolini, T.2
Colombo, M.3
Bollani, S.4
Benvegnu, L.5
Mazzella, G.6
-
8
-
-
79957982710
-
IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-alpha plus ribavirin therapy in Taiwanese chronic HCV infection
-
Chen, J.Y., Lin, C.Y., Wang, C.M., Lin, Y.T., Kuo, S.N., Shiu, C.F., et al. 2011. IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-alpha plus ribavirin therapy in Taiwanese chronic HCV infection. Genes Immun. 12(4): 300–309. doi:10.1038/gene.2011.1. PMID:21346780.
-
(2011)
Genes Immun
, vol.12
, Issue.4
, pp. 300-309
-
-
Chen, J.Y.1
Lin, C.Y.2
Wang, C.M.3
Lin, Y.T.4
Kuo, S.N.5
Shiu, C.F.6
-
9
-
-
67651240586
-
Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy
-
Conca, P., and Tarantino, G. 2009. Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy. World J. Gastroenterol. 15(19): 2305–2308. doi:10.3748/wjg.15.2305. PMID: 19452570.
-
(2009)
World J. Gastroenterol
, vol.15
, Issue.19
, pp. 2305-2308
-
-
Conca, P.1
Tarantino, G.2
-
10
-
-
38649090068
-
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
-
Dalgard, O., Bjoro, K., Ring-Larsen, H., Bjornsson, E., Holberg-Petersen, M., Skovlund, E., et al. 2008. Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response. Hepatology, 47(1): 35–42. doi:10.1002/hep.21975. PMID:17975791.
-
(2008)
Hepatology
, vol.47
, Issue.1
, pp. 35-42
-
-
Dalgard, O.1
Bjoro, K.2
Ring-Larsen, H.3
Bjornsson, E.4
Holberg-Petersen, M.5
Skovlund, E.6
-
11
-
-
75149163334
-
Aging of hepatitis C virus (HCV)-infected persons in the United States: A multiple cohort model of HCV prevalence and disease progression
-
Davis, G.L., Alter, M.J., El-Serag, H., Poynard, T., and Jennings, L.W. 2010. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology, 138(2): 513–521, 521 e511-516. doi:10.1053/j.gastro.2009.09.067. PMID:19861128.
-
(2010)
Gastroenterology
, vol.138
, Issue.2
-
-
Davis, G.L.1
Alter, M.J.2
El-Serag, H.3
Poynard, T.4
Jennings, L.W.5
-
12
-
-
84873895893
-
Interleukin-28 and hepatitis C virus genotype-4: Treatment-induced clearance and liver fibrosis
-
Derbala, M., Rizk, N., Shebl, F., Alkaabi, S., Eldweik, N., John, A., et al. 2012. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis. World J. Gastroenterol. 18(47): 7003–7008. doi:10.3748/wjg.v18.i47.7003. PMID:23323000.
-
(2012)
World J. Gastroenterol
, vol.18
, Issue.47
, pp. 7003-7008
-
-
Derbala, M.1
Rizk, N.2
Shebl, F.3
Alkaabi, S.4
Eldweik, N.5
John, A.6
-
13
-
-
0032583933
-
-
Di Bisceglie, A.M. 1998. Hepatitis C. Lancet, 351(9099): 351–355. doi:10.1016/S0140-6736(97)07361-3. PMID:9652633.
-
(1998)
Hepatitis C. Lancet
, vol.351
, Issue.9099
, pp. 351-355
-
-
Di Bisceglie, A.M.1
-
14
-
-
69549135689
-
The autophagy machinery is required to initiate hepatitis C virus replication
-
Dreux, M., Gastaminza, P., Wieland, S.F., and Chisari, F.V. 2009. The autophagy machinery is required to initiate hepatitis C virus replication. Proc. Natl. Acad. Sci. U.S.A. 106(33): 14046–14051. doi:10.1073/pnas.0907344106. PMID:19666601.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, Issue.33
, pp. 14046-14051
-
-
Dreux, M.1
Gastaminza, P.2
Wieland, S.F.3
Chisari, F.V.4
-
15
-
-
84892529894
-
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
-
European Association for the Study of the Liver. 2014. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J. Hepatol. 60(2): 392–420. doi:10.1016/j.jhep.2013.11.003. PMID:24331294.
-
(2014)
J. Hepatol
, vol.60
, Issue.2
, pp. 392-420
-
-
-
16
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales, F.L., Jr., et al. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347(13): 975–982. doi:10.1056/NEJMoa020047. PMID:12324553.
-
(2002)
N. Engl. J. Med
, vol.347
, Issue.13
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales, F.L.6
-
17
-
-
84890803688
-
Autophagy and apoptosis dysfunction in neurodegenerative disorders
-
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S.R., Jangamreddy, J.R., Mehrpour, M., et al. 2014. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol. 112: 24–49. doi:10.1016/j.pneurobio.2013.10.004. PMID: 24211851.
-
(2014)
Prog. Neurobiol
, vol.112
, pp. 24-49
-
-
Ghavami, S.1
Shojaei, S.2
Yeganeh, B.3
E, S.R.4
Jangamreddy, J.R.5
Mehrpour, M.6
-
18
-
-
0031862379
-
Assessment of spontaneous fluctuations of viral load in untreated patients with chronic hepatitis C by two standardized quantitation methods: Branched DNA and Amplicor Monitor
-
Halfon, P., Bourliere, M., Halimi, G., Khiri, H., Bertezene, P., Portal, I., et al. 1998. Assessment of spontaneous fluctuations of viral load in untreated patients with chronic hepatitis C by two standardized quantitation methods: branched DNA and Amplicor Monitor. J. Clin. Microbiol. 36(7): 2073–2075. PMID:9650965.
-
(1998)
J. Clin. Microbiol
, vol.36
, Issue.7
, pp. 2073-2075
-
-
Halfon, P.1
Bourliere, M.2
Halimi, G.3
Khiri, H.4
Bertezene, P.5
Portal, I.6
-
19
-
-
33845424075
-
Equal amounts of intracellular and virion-enclosed hepatitis C virus RNA are associated with peripheral-blood mononuclear cells in vivo
-
Kaiser, P., Niederost, B., Joos, B., von Wyl, V., Opravil, M., Weber, R., et al. 2006. Equal amounts of intracellular and virion-enclosed hepatitis C virus RNA are associated with peripheral-blood mononuclear cells in vivo. J. Infect. Dis. 194(12): 1713–1723. doi:10.1086/508431. PMID:17109344.
-
(2006)
J. Infect. Dis
, vol.194
, Issue.12
, pp. 1713-1723
-
-
Kaiser, P.1
Niederost, B.2
Joos, B.3
Von Wyl, V.4
Opravil, M.5
Weber, R.6
-
20
-
-
78650961487
-
Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro
-
Ke, P.Y., and Chen, S.S. 2011. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J. Clin. Invest. 121(1): 37–56. doi:10.1172/JCI41474. PMID:21135505.
-
(2011)
J. Clin. Invest
, vol.121
, Issue.1
, pp. 37-56
-
-
Ke, P.Y.1
Chen, S.S.2
-
21
-
-
0034537290
-
Autophagy as a regulated pathway of cellular degradation
-
Klionsky, D.J., and Emr, S.D. 2000. Autophagy as a regulated pathway of cellular degradation. Science, 290(5497): 1717–1721. doi:10.1126/science.290.5497.1717. PMID:11099404.
-
(2000)
Science
, vol.290
, Issue.5497
, pp. 1717-1721
-
-
Klionsky, D.J.1
Emr, S.D.2
-
22
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, R., et al. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 358(9286): 958–965. doi:10.1016/S0140-6736(01)06102-5. PMID:11583749.
-
(2001)
Lancet
, vol.358
, Issue.9286
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
-
23
-
-
77949264265
-
Inhibition of hepatitis C virus replication by chloroquine targeting virusassociated autophagy
-
Mizui, T., Yamashina, S., Tanida, I., Takei, Y., Ueno, T., Sakamoto, N., et al. 2010. Inhibition of hepatitis C virus replication by chloroquine targeting virusassociated autophagy. J. Gastroenterol. 45(2): 195–203. doi:10.1007/s00535-009-0132-9. PMID:19760134.
-
(2010)
J. Gastroenterol
, vol.45
, Issue.2
, pp. 195-203
-
-
Mizui, T.1
Yamashina, S.2
Tanida, I.3
Takei, Y.4
Ueno, T.5
Sakamoto, N.6
-
24
-
-
36249025723
-
Autophagy: Process and function
-
Mizushima, N. 2007. Autophagy: process and function. Genes Dev. 21(22): 2861–2873. doi:10.1101/gad.1599207. PMID:18006683.
-
(2007)
Genes Dev
, vol.21
, Issue.22
, pp. 2861-2873
-
-
Mizushima, N.1
-
25
-
-
37649018343
-
The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy
-
Mosley, J.W., Operskalski, E.A., Tobler, L.H., Buskell, Z.J., Andrews, W.W., Phelps, B., et al. 2008. The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy. J. Viral Hepat. 15(2): 120–128. doi:10.1111/j.1365-2893.2007.00900.x. PMID:18184195.
-
(2008)
J. Viral Hepat
, vol.15
, Issue.2
, pp. 120-128
-
-
Mosley, J.W.1
Operskalski, E.A.2
Tobler, L.H.3
Buskell, Z.J.4
Rews, W.W.5
Phelps, B.6
-
26
-
-
57649166494
-
Eating the enemy within: Autophagy in infectious diseases
-
Orvedahl, A., and Levine, B. 2009. Eating the enemy within: autophagy in infectious diseases. Cell Death Differ. 16(1): 57–69. doi:10.1038/cdd.2008.130. PMID: 18772897.
-
(2009)
Cell Death Differ
, vol.16
, Issue.1
, pp. 57-69
-
-
Orvedahl, A.1
Levine, B.2
-
27
-
-
0019866088
-
Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages
-
Poole, B., and Ohkuma, S. 1981. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell Biol. 90(3): 665–669. doi:10.1083/jcb.90.3.665. PMID:6169733.
-
(1981)
J. Cell Biol
, vol.90
, Issue.3
, pp. 665-669
-
-
Poole, B.1
Ohkuma, S.2
-
28
-
-
84912142412
-
Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?
-
Pourhoseingholi, M.A., Ashtari, S., and Alavian, S.M. 2014. Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients? Hepat. Mon. 14(11): e25540. doi:10.5812/hepatmon.25540. PMID:25598793.
-
(2014)
Hepat. Mon
, vol.14
, Issue.11
-
-
Pourhoseingholi, M.A.1
Ashtari, S.2
Alavian, S.M.3
-
29
-
-
0036242165
-
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
-
Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., et al. 2002. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology, 122(5): 1303–1313. doi:10.1053/gast.2002.33023. PMID:11984517.
-
(2002)
Gastroenterology
, vol.122
, Issue.5
, pp. 1303-1313
-
-
Poynard, T.1
McHutchison, J.2
Manns, M.3
Trepo, C.4
Lindsay, K.5
Goodman, Z.6
-
30
-
-
84881623229
-
How positive-strand RNA viruses benefit from autophagosome maturation
-
Richards, A.L., and Jackson, W.T. 2013. How positive-strand RNA viruses benefit from autophagosome maturation. J. Virol. 87(18): 9966–9972. doi:10.1128/JVI.00460-13. PMID:23760248.
-
(2013)
J. Virol
, vol.87
, Issue.18
, pp. 9966-9972
-
-
Richards, A.L.1
Jackson, W.T.2
-
31
-
-
34548460117
-
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
-
Rolain, J.M., Colson, P., and Raoult, D. 2007. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int. J. Antimicrob. Agents, 30(4): 297–308. doi:10.1016/j.ijantimicag.2007.05.015. PMID:17629679.
-
(2007)
Int. J. Antimicrob. Agents
, vol.30
, Issue.4
, pp. 297-308
-
-
Rolain, J.M.1
Colson, P.2
Raoult, D.3
-
32
-
-
12344300756
-
Random allocation software for parallel group randomized trials
-
Saghaei, M. 2004. Random allocation software for parallel group randomized trials. BMCMed. Res. Methodol. 4: 26. doi:10.1186/1471-2288-4-26. PMID:15535880.
-
(2004)
Bmcmed. Res. Methodol
, vol.4
-
-
Saghaei, M.1
-
33
-
-
0242355070
-
Effects of chloroquine on viral infections: An old drug against today’s diseases?
-
Savarino, A., Boelaert, J.R., Cassone, A., Majori, G., and Cauda, R. 2003. Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect. Dis. 3(11): 722–727. doi:10.1016/S1473-3099(03)00806-5. PMID:14592603.
-
(2003)
Lancet Infect. Dis
, vol.3
, Issue.11
, pp. 722-727
-
-
Savarino, A.1
Boelaert, J.R.2
Cassone, A.3
Majori, G.4
Cauda, R.5
-
34
-
-
0028903955
-
Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone
-
Schvarcz, R., Yun, Z.B., Sonnerborg, A., and Weiland, O. 1995. Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. J. Med. Virol. 46(1): 43–47. doi:10.1002/jmv.1890460110. PMID:7623006.
-
(1995)
J. Med. Virol
, vol.46
, Issue.1
, pp. 43-47
-
-
Schvarcz, R.1
Yun, Z.B.2
Sonnerborg, A.3
Weiland, O.4
-
35
-
-
79251512287
-
Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes
-
Shrivastava, S., Raychoudhuri, A., Steele, R., Ray, R., and Ray, R.B. 2011. Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes. Hepatology, 53(2): 406–414. doi:10.1002/hep.24073. PMID:21274862.
-
(2011)
Hepatology
, vol.53
, Issue.2
, pp. 406-414
-
-
Shrivastava, S.1
Raychoudhuri, A.2
Steele, R.3
Ray, R.4
Ray, R.B.5
-
36
-
-
70349634804
-
Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles
-
Tanida, I., Fukasawa, M., Ueno, T., Kominami, E., Wakita, T., and Hanada, K. 2009. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy, 5(7): 937–945. doi:10.4161/auto.5.7.9243. PMID:19625776.
-
(2009)
Autophagy
, vol.5
, Issue.7
, pp. 937-945
-
-
Tanida, I.1
Fukasawa, M.2
Ueno, T.3
Kominami, E.4
Wakita, T.5
Hanada, K.6
-
37
-
-
71549119489
-
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?
-
Tarantino, G., Citro, V., Conca, P., Riccio, A., Tarantino, M., Capone, D., et al. 2009a. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol. 9: 89. doi:10.1186/1471-230X-9-89. PMID:19930687.
-
(2009)
BMC Gastroenterol
, vol.9
-
-
Tarantino, G.1
Citro, V.2
Conca, P.3
Riccio, A.4
Tarantino, M.5
Capone, D.6
-
38
-
-
64049105177
-
Blood ammonia levels in liver cirrhosis: A clue for the presence of portosystemic collateral veins
-
Tarantino, G., Citro, V., Esposito, P., Giaquinto, S., de Leone, A., Milan, G., et al. 2009b. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 9: 21. doi:10.1186/1471-230X-9-21. PMID:19292923.
-
(2009)
BMC Gastroenterol
, vol.9
-
-
Tarantino, G.1
Citro, V.2
Esposito, P.3
Giaquinto, S.4
De Leone, A.5
Milan, G.6
-
39
-
-
12444260678
-
Randomized, controlled trial with IFN-alpha combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C
-
Teuber, G., Pascu, M., Berg, T., Lafrenz, M., Pausch, J., Kullmann, F., et al. 2003. Randomized, controlled trial with IFN-alpha combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C. J. Hepatol. 39(4): 606–613. doi:10.1016/S0168-8278(03)00298-8. PMID:12971972.
-
(2003)
J. Hepatol
, vol.39
, Issue.4
, pp. 606-613
-
-
Teuber, G.1
Pascu, M.2
Berg, T.3
Lafrenz, M.4
Pausch, J.5
Kullmann, F.6
-
40
-
-
84893824447
-
Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis
-
Thome, R., Issayama, L.K., DiGangi, R., Bombeiro, A.L., da Costa, T.A., Ferreira, I.T., et al. 2014. Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis. Immunol. Cell Biol. 92(2): 124–132. doi:10.1038/icb.2013.73. PMID:24217811.
-
(2014)
Immunol. Cell Biol
, vol.92
, Issue.2
, pp. 124-132
-
-
Thome, R.1
Issayama, L.K.2
Digangi, R.3
Bombeiro, A.L.4
Da Costa, T.A.5
Ferreira, I.T.6
-
41
-
-
84855824374
-
Autophagy required for hepatitis B virus replication in transgenic mice
-
Tian, Y., Sir, D., Kuo, C.F., Ann, D.K., and Ou, J.H. 2011. Autophagy required for hepatitis B virus replication in transgenic mice. J. Virol. 85(24): 13453–13456. doi:10.1128/JVI.06064-11. PMID:21957292.
-
(2011)
J. Virol
, vol.85
, Issue.24
, pp. 13453-13456
-
-
Tian, Y.1
Sir, D.2
Kuo, C.F.3
Ann, D.K.4
Ou, J.H.5
-
42
-
-
2442715159
-
Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]
-
Veldt, B.J., Brouwer, J.T., Adler, M., Nevens, F., Michielsen, P., Delwaide, J., et al. 2003. Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]. BMC Gastroenterol. 3: 24. PMID:12948399.
-
(2003)
BMC Gastroenterol
, vol.3
-
-
Veldt, B.J.1
Brouwer, J.T.2
Adler, M.3
Nevens, F.4
Michielsen, P.5
Delwaide, J.6
-
43
-
-
23844542010
-
Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride
-
Verbeeck, R.K., Junginger, H.E., Midha, K.K., Shah, V.P., and Barends, D.M. 2005. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride. J. Pharm. Sci. 94(7): 1389–1395. doi:10.1002/jps.20343. PMID:15920763.
-
(2005)
J. Pharm. Sci
, vol.94
, Issue.7
, pp. 1389-1395
-
-
Verbeeck, R.K.1
Junginger, H.E.2
Midha, K.K.3
Shah, V.P.4
Barends, D.M.5
-
44
-
-
0347626252
-
Autophagy: A regulated bulk degradation process inside cells
-
Yoshimori, T. 2004. Autophagy: a regulated bulk degradation process inside cells. Biochem. Biophys. Res. Commun. 313(2): 453–458. doi:10.1016/j.bbrc.2003.07.023. PMID:14684184.
-
(2004)
Biochem. Biophys. Res. Commun
, vol.313
, Issue.2
, pp. 453-458
-
-
Yoshimori, T.1
-
45
-
-
0026761707
-
Infection of peripheral mononuclear blood cells by hepatitis C virus
-
Zignego, A.L., Macchia, D., Monti, M., Thiers, V., Mazzetti, M., Foschi, M., et al. 1992. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 15(3): 382–386. doi:10.1016/0168-8278(92)90073-X. PMID:1332999.
-
(1992)
J. Hepatol
, vol.15
, Issue.3
, pp. 382-386
-
-
Zignego, A.L.1
Macchia, D.2
Monti, M.3
Thiers, V.4
Mazzetti, M.5
Foschi, M.6
|